Radiopharm Theranostics gets positive DSMC recommendation for 177Lu-RAD202 trial
Radiopharm Theranostics says its Data Safety and Monitoring Committee issued a positive recommendation to advance to Cohort 4 in the Phase 1 HEAT clinical trial of 177Lu-RAD202.